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A. Specific Aims  
The original grant proposal contained two specific aims. These aims remain unchanged at this point in the pro-
gram. The overarching goals of the program relate to the development of multi-responsive/functional hydrogel 
nanoparticles for cancer cell targeting.  This is to be accomplished in the following specific aims: 
Aim 1: To utilize doxorubicin-loaded, folate-modified, degradable core/shell microgels to target cells in 
vitro to specifically evade P-glycoprotein based multi-drug resistance. This aim will demonstrate that the 
core/shell microgel construct is effective in cellular targeting, that the designed degradation pathways enable 
cytosolic delivery of an anti-tumor agent (doxorubicin), and that the construct enables the evasion of multi-drug 
resistance that arises from P-glycoprotein overexpression. 
Aim 2: To develop multi-functional core/shell microgels that “display” folate in response to specific 
matrix metalloproteinase (MMP) activity. Taking advantage of elevated MMP activity proximal to tumor 
growth, these microgels will have “stealth” properties that allow for folate display, cell surface binding, and en-
docytosis only after exposure to elevated MMP activity. This will further reduce the potential for binding and 
uptake of the vehicles by healthy tissues. 
 
B. Studies and Results 
(1) Core/shell nanogel synthesis 
In order to investigate the impact of different nanogels on cellular uptake, we 
have optimized the syntheses of ~100-nm diameter core/shell nanogels com-
posed of various polymers and characterized them by light scattering tech-
niques.  The table below summarizes the different particles prepared, where 
pNIPAm is poly(N-isopropylacrylamide), pNIPMAm is poly(N-
isopropylmethacrylamide), AFA is acryloylfluorescein (fluorescent co-
monomer), PEG is a 575MW poly(ethyleneglycol diacrylate) cross-linker, and 
APMA is aminopropyl methacrylamide (amine sidechain co-monomer).  All 
nanogels have subsequently been modified with folic acid for cell targeting 
studies. Folic acid loading has been quantified spectrophotometrically. 
As described in the original proposal, the PEG cross-linkers are being added 
to resist non-specific adsorption of protein. These particles will allow for in 
vitro comparisons to be made between the two types of particles. 
 
(2) Degradable cross-linkers 
The synthesis of degradable particles was a key aspect of the original pro-
posal.  A series of ketal-based cross-linkers were originally proposed, but it 
was found early on that these cross-linkers were not well behaved in our 
core/shell nanogel syntheses. We have subsequently focused on two main 
cross-linker types. The first is N-(methacryloyloxy)methacrylamide, which is 
shown in Figure 1. Whereas the literature suggests that the exotic “Lossen 
Rearrangement” is associated with its cleavage, we have recently shown that 
the cross-linker erodes hydrolytically. We have prepared the cross-linker in 
our labs, and have prepared both nanogels and macroscopic gels containing 
this cross-linker. The nanogel erosion data are extremely encouraging. 
Entry Core composition Shell composition Total size (radius) 
1 pNIPAm-AFA pNIPAM-APMA 52 nm 
2 pNIPAm-AFA pNIPAM-PEG-APMA 49 nm 
3 pNIPMAm-AFA pNIPMAM-APMA 55 nm 









Figure 1. A novel degradable 
cross-linker, which decom-
poses via the Lossen rear-
rangement. 
Figure 2. DMHA cross-linked 
nanogel degradation as deter-
mined by AFM imaging of nano-
gel films as a function of solution 
conditions (pH 5 vs. serum con-
taining culture medium).  
Atomic force microscopy of substrate-supported, degradable nanogels show erosion rates (particle height de-
creases) commensurate with typical circulation/deposition times for nanoparticles (Figure 2). Importantly, we 
have been able to incorporate this cross-linker into the appropriate core/shell architectures; a scheme of the 
synthetic method is shown in Figure 3. 
 
(3) Orthogonal chemoligation on nanogels 
We have developed a simple, 1-pot method for 
the synthesis of azido-functionalized microgels that is 
completely compatible with all of the core/shell syn-
theses developed by the Lyon group over the last 
decade. The microgel synthetic scheme is shown in 
Figure 4. As a preliminary test of this particle’s utility 
in ‘click’ chemistries, we performed Cu-catalyzed 3-2 
dipolar cycloaddition between the microgel-localized 
azido groups and the alkyne moiety on propargylfluo-
rescein thiourea. Following purification by centrifuga-
tion and resuspension in water, a dilute solution of the 
particles was dried on a coverslip for microscopic ob-
servation. Figure 4 shows a representative fluores-
cence micrograph of these particles illustrating the 
very bright, microgel localized fluo-
rescence. This is clear indication of 
the success of the coupling reac-
tion; we are currently exploring the 
efficiency of this reaction in the 
coupling of alkyne-modified pep-
tides. 
 
(4) Cellular uptake studies 
Finally, we have explored the up-
take of non-degradable, folate-
modified, core/shell nanogels in var-
ious KB cell lines. Preliminary re-
sults indicate that the pNIPMAm-
based nanogels perform somewhat better in 
vitro than the pNIPAm-based counterparts. 
This is largely due to some aggregation of the 
latter.  In preliminary studies, pNIPMAm-based 
nanogels functionalized with folic acid show 
~2-fold greater uptake than the cationic, fo-
late(-) control particles. We are currently opti-
mizing the syntheses with respect to folate 
loading so as to increase the degree of differ-
ential uptake.  
 
We have also investigated the generality of the 
construct by using a peptide-based targeting 
approach. We enlisted the assistance of Prof. John McDonald’s group here at GT for the sake of expedience, 
and because of their experience with the ‘YSA’ peptide (YSAYPDSVPMMSC, a peptide-mimetic of ephrinA1). 
In this architecture, the fluorescent core enables tracking and imaging via confocal fluorescence microscopy, 



















































Figure 3. Two-stage synthesis of core/shell nanogels. 
Note that the amine co-monomer is used for coupling the 
targeting ligand to the shell. 
Figure 4. Azido-microgel synthesis and coupling. (Left) Reaction scheme for 1-
pot azido microgel synthesis. This reaction can be extended to PEG-
containing, non-fouling microgel synthesis by changing the cross-linker to a
PEG-diacrylate. (Right) Fluorescence microscopy image of azido-microgels
following a “click” reaction with a propargylfluorescein dye.  
Figure 5. Confocal microscopy images of Hey cells following a 4-
hour incubation with YSA-targeted, fluorescent pNIPMAm 
core/shell nanogels loaded with siRNA. (left) Particle fluorescence, 
(middle) siRNA fluorescence, (right) overlaid images. 
on the surface of many ovarian carcinomas and also in neovasculature associated with tumors, making it very 
attractive for ovarian tumor targeting applications. To evaluate the efficacy of peptide-mediated targeting, we 
evaluated targeting to Hey cells (an ovarian cancer cell line). The Hey cells were incubated with either uncon-
jugated nanogels or nanogels conjugated with the YSA peptide. The peptide-conjugated nanogels were pref-
erentially taken up by the cells over non-targeted nanogels, as observed by fluorescence microscopy. The 
McDonald group is also very interested in the therapeutic potential of siRNA in cancer delivery. We used our 
nanogels to load siRNA and deliver it to Hey cells via peptide targeting. The excellent preliminary results 
shown in Figure 5 illustrate the potential of nanogels for targeted delivery of therapeutics. 
 
C. Significance 
This work is significant in multiple ways. From the basic science perspective, it represents by far the most 
complex hydrogel nanoparticle architectures prepared to date. This work is cutting-edge with respect to the 
topological design of nanoparticles for biomedical applications. From the perspective of human health, these 
materials represent the next step in nanotechnology’s contributions to healthcare. While targeted drug delivery 
vehicles have existed (in the laboratory) for some time, rationally designed architectures such as these should 
make a significant impact as the field moves forward to clinical relevance. 
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